| Bioactivity | PLGA (50:50) (poly(lactic-co-glycolic acid) (50:50)) is a copolymer of poly lactic acid (PLA) and poly glycolic acid (PGA) which can be used to fabricate devices for drug delivery and tissue engineering applications. | ||||||||||||
| Name | PLGA (50:50) | ||||||||||||
| CAS | 34346-01-5 | ||||||||||||
| Formula | C5H8O5 | ||||||||||||
| Molar Mass | 10000-20000 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Makadia HK, et al. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel). 2011 Sep 1;3(3):1377-1397. |
PLGA (50:50)
CAS: 34346-01-5 F: C5H8O5 W: 10000-20000
PLGA (50:50) (poly(lactic-co-glycolic acid) (50:50)) is a copolymer of poly lactic acid (PLA) and poly glycolic acid (PG
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.